Want to see JP:4671 full AI Analyst Report?
FALCO HOLDINGS Co., Ltd (4671) Stock Price & Analysis
4671 Stock Chart & Stats
- Day’s Range
- JPY 2,623.00 - JPY 2,718.00
- 52-Week Range
- JPY 2,470.00 - JPY 2,964.00
- Previous Close
- JPY 2,593.00
- Volume
- 5,900
- Average Volume (3M)
- 19.01K
- Market Cap
- JPY 26.66B
- Enterprise Value
- JPY 18.12B
- Total Cash (Recent Filing)
- JPY 8.68B
- Total Debt (Recent Filing)
- JPY 1.02B
- Price to Earnings (P/E)
- 13.0
- Beta
- 0.52
- Next Earnings
- Nov 06, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Mar 31, 2027
- Dividend Yield
- 4.66%
Bulls Say, Bears Say
Bulls Say
Low Financial Leverage
Very low and improving leverage gives FALCO substantial financial flexibility. The company is less dependent on borrowing, reducing solvency risk and preserving capacity to fund operations, investment, or shareholder returns through changing conditions.
Positive Cash Generation
Consistently positive operating and free cash flow indicates that the laboratory-services model generates internal funding. This supports ongoing operations and reduces reliance on external capital, even though conversion quality remains uneven.
Revenue Reacceleration
The return to double-digit revenue growth suggests demand and business activity have regained momentum after the earlier contraction. Sustained growth would improve operating leverage and provide a stronger base for earnings recovery.
Bears Say
Margin Compression
Although profitability remains positive, lower operating and net margins indicate that earnings power is weaker than at the 2022 peak. Persistent compression could limit profit growth even if revenue continues recovering.
Uneven Free Cash Flow Quality
Positive cash generation is tempered by weak conversion from accounting earnings and significant year-to-year volatility. This makes internally generated funds less predictable and could constrain the timing or scale of investment and distributions.
Recent Revenue History
The recent recovery follows a multi-year period of contraction and only modest growth in 2025. That history indicates uncertainty over the durability of the latest acceleration and leaves the company exposed if demand or test volumes soften.
4671 FAQ
What was FALCO HOLDINGS Co., Ltd’s price range in the past 12 months?
What is FALCO HOLDINGS Co., Ltd’s market cap?
When is FALCO HOLDINGS Co., Ltd’s upcoming earnings report date?
How were FALCO HOLDINGS Co., Ltd’s earnings last quarter?
Is FALCO HOLDINGS Co., Ltd overvalued?
Does FALCO HOLDINGS Co., Ltd pay dividends?
What is FALCO HOLDINGS Co., Ltd’s EPS estimate?
How many shares outstanding does FALCO HOLDINGS Co., Ltd have?
What happened to FALCO HOLDINGS Co., Ltd’s price movement after its last earnings report?
Which hedge fund is a major shareholder of FALCO HOLDINGS Co., Ltd?
What is the TipRanks Smart Score and how is it calculated?
Company Description
FALCO HOLDINGS Co., Ltd
FALCO HOLDINGS Co., Ltd., a medical services enterprise established in 1962 and headquartered in Kyoto, Japan, primarily delivers clinical diagnostic testing and pharmaceutical dispensing solutions. The company serves medical institutions and various corporations throughout Japan. Its comprehensive range of clinical testing encompasses specialized areas such as genetics, biochemistry, hematology, pathology, immunology, microbiology, and radioimmunoassay. Beyond direct diagnostics, FALCO HOLDINGS also engages in genomic-based drug discovery and the development of biotechnological pharmaceuticals. The company's offerings extend to medical information technology services, as well as environmental and food sanitation testing. They also provide genetic testing tailored for the food industry, catering to manufacturers, retailers, and restaurants. Additionally, FALCO HOLDINGS operates dispensing pharmacies and drugstores. They are also active in the development and sale of medical information systems, notably including "@home Dr.," an electronic medical record system designed for clinics with a high volume of clinical testing, and "TASCAL for ASP," a robust medical support system.
- Sector
- General
- Industry
- Medical - Diagnostics & Research
- CEO
- Tadashi Yasuda
- Employees
- 1,037
- Website
- www.falco-hd.co.jp
- Address
- 1-3-7, Uchihiranomachi Chuo-ku, Osaka, KY, 540-0037, JP
FALCO HOLDINGS Co., Ltd (4671) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 6 | 2 |
| Technical Analysis | 3 | 6 | 1 |
| Moving Averages | 11 | 0 | 1 |